Are younger men with erectile dysfunction (ED) at considerably higher risk of heart disease, and if so, why? It is known that the condition can be an important predictor of coronary events, but with men under age fifty, it appears there is an interval between the onset of ED and the onset of heart trouble. Could this change our approach to treating younger men with ED, and perhaps delaying or preventing cardiovascular disease? Dr. Martin Miner, co-director of the Men's Health Center at Miriam Hospital in Providence, Rhode Island, explains how he would evaluate the younger patient who presents with erectile dysfunction in this conversation with host Dr. Larry Kaskel.
Erectile Dysfunction: A Window Into Cardiovascular Health
Restart
Resume
Share this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Recommended
Details
Presenters
Overview
Are younger men with erectile dysfunction (ED) at considerably higher risk of heart disease, and if so, why? It is known that the condition can be an important predictor of coronary events, but with men under age fifty, it appears there is an interval between the onset of ED and the onset of heart trouble. Could this change our approach to treating younger men with ED, and perhaps delaying or preventing cardiovascular disease? Dr. Martin Miner, co-director of the Men's Health Center at Miriam Hospital in Providence, Rhode Island, explains how he would evaluate the younger patient who presents with erectile dysfunction in this conversation with host Dr. Larry Kaskel.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
CME/CE
Innovations in the Management of Hemolytic Disease of the Fetus and Newborn: The Role of the Neonatal Fc Receptor (FcRn) Pathway
0.25 credits
<p>Innovations in the Management of Hemolytic Disease of the Fetus and Newborn: The Role of the Neonatal Fc Receptor (FcRn) Pathway</p>
CME/CE
Evolving Our View of the Coagulation Cascade and Stroke Management
0.25 credits
<p><span data-contrast="auto" xml:lang="EN-US">Evolving Our View of the Coagulation Cascade and Stroke Management</span><span data-ccp-props='{"201341983":0,"335559739":0,"335559740":240}'> </span></p>
CME/CE
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
0.25 credits
<p>Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective</p>
MinuteCE®
I'm Getting the Hang of This! I Have Two Patients: One At 'Indeterminate Risk' and One At 'High Risk' for Clinically Significant Fibrosis
1.00 credits
<p>I'm Getting the Hang of This! I Have Two Patients: One At 'Indeterminate Risk' and One At 'High Risk' for Clinically Significant Fibrosis</p>
MinuteCE®
M3: Managing the Cardiometabolic Risk in MASH
1.00 credits
<p><span data-contrast="auto" xml:lang="EN-US">M3: Managing the Cardiometabolic Risk in MASH</span><span data-ccp-props='{"201341983":0,"335559739":160,"335559740":259}'> </span></p>
MinuteCE®
Beyond Longevity: Discussing TAVR Durability for Women & Patients With Small Annuli
1.00 credits
<p><span data-contrast="none" xml:lang="EN-US">Beyond Longevity: Discussing TAVR Durability for Women & Patients With Small Annuli</span> </p>
MinuteCE®
HF Management for Patients with Comorbid Conditions
0.75 credits
<p>HF Management for Patients with Comorbid Conditions</p>
CME/CE
Impact of Barostim on Heart Failure Hospitalization
<p>Impact of Barostim on Heart Failure Hospitalization</p>
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?